|
1.
|
Sweet RD: An acute febrile neutrophilic
dermatosis. Br J Dermatol. 76:349–356. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Cohen PR: Sweet’s syndrome: a
comprehensive review of an acute febrile neutrophilic dermatosis.
Orphanet J Rare Dis. 2:342007.
|
|
3.
|
Su WPD and Liu H-NH: Diagnostic criteria
for Sweet’s syndrome. Cutis. 37:167–174. 1986.
|
|
4.
|
von den Driesch P: Sweet’s syndrome (acute
febrile neutrophilic dermatosis). J Am Acad Dermatol. 31:535–556.
1994.
|
|
5.
|
Cohen PR and Kurzrock R: Sweet’s syndrome
and cancer. Clin Dermatol. 11:149–157. 1993.
|
|
6.
|
Paydas S: Sweet’s syndrome: a revisit for
hematologists and oncologists. Crit Rev Oncol Hematol. Oct
6–2012.(Epub ahead of print). View Article : Google Scholar
|
|
7.
|
Cohen PR, Talpaz M and Kurzrock R:
Malignancy-associated Sweet’s syndrome: review of the world
literature. J Clin Oncol. 6:1887–1897. 1988.
|
|
8.
|
Haverstock C, Libecco JF, Sadeghi P, et
al: Tender erythematous plaques in a woman with acute myelogenous
leukemia. Arch Dermatol. 142:235–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Disel U, Paydas S, Yavuz S, et al:
Bilateral ear Sweet’s syndrome in a case with relapse acute
myeloblastic leukemia. Leuk Res. 30:3642006.
|
|
10.
|
Cohen PR: Cutaneous paraneoplastic
syndromes. Am Fam Physician. 50:1273–1282. 1994.PubMed/NCBI
|
|
11.
|
Kurzrock R and Cohen PR: Mucocutaneous
paraneoplastic manifestations of hematologic malignancies. Am J
Med. 99:207–216. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kurzrock R and Cohen PR: Cutaneous
paraneoplastic syndromes in solid tumors. Am J Med. 99:662–671.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Cohen PR: Cutaneous manifestations of
internal malignancy. Section V, Dermatology. Current Practice of
Medicine. Callen JP and Bone RC: Current Medicine, Philadelphia,
PA, Inc; 2(V): pp. 19.1–19.3. 1996
|
|
14.
|
Cohen PR and Kurzrock R: Paraneoplastic
syndromes of the skin. Current Diagnosis 9. Conn RB, Borer WZ and
Snyder JW: W.B. Saunders Co; Philadelphia, PA: pp. 1199–1206.
1997
|
|
15.
|
Morgan KW, Callen JP and Kentucky L:
Sweet’s syndrome in acute myelogenous leukemia presenting as
periorbital cellulitis with an infiltrate of leukemic cells. J Am
Acad Dermatol. 45:590–595. 2001.
|
|
16.
|
Caughman W, Stern R and Haynes H:
Neutrophilic dermatosis of myeloproliferative disorders: atypical
forms of pyoderma gangrenosum and Sweet’s syndrome associated with
myeloproliferative disorders. J Am Acad Dermatol. 9:751–758.
1983.PubMed/NCBI
|
|
17.
|
Bamelis M, Boyden B, Sente F, et al:
Sweet’s syndrome and acute myelogenous leukemia in a patient who
presented with a sudden massive swelling of the tongue.
Dermatology. 190:335–337. 1995.
|
|
18.
|
García-Río I, Pérez-Gala S, Aragüés M, et
al: Sweet’s syndrome on the area of postmastectomy lymphoedema. J
Eur Acad Dermatol Venereol. 20:401–405. 2006.
|
|
19.
|
Matta M and Kurban AK: Sweet’s syndrome:
systemic association. Cutis. 12:561–565. 1973.
|
|
20.
|
Elsner P, Hartmann AA and Lechner W:
Sweet’s syndrome associated with Yersinia enterocolitica infection.
Dermatologica. 173:85–89. 1986.
|
|
21.
|
Arun B, Berberian B, Azumi N, et al:
Sweet’s syndrome during treatment with all-trans retinoic acid in a
patient with acute promyelocytic leukemia. Leuk Lymphoma.
31:613–615. 1998.
|
|
22.
|
Paydas S, Sahin B and Zorludemir S:
Sweet’s syndrome accompanying leukaemia: seven cases and review of
the literature. Leuk Res. 24:83–86. 2000.
|
|
23.
|
Arbetter KR, Hubbard KW, Markovic SN, et
al: Case of granulocytic colony-stimulating factor-induced Sweet’s
syndrome. Am J Hematol. 61:126–129. 1999.PubMed/NCBI
|
|
24.
|
Giasuddin AS, El-Orfi AH, Ziu MM and
El-Barnawi NY: Sweet’s syndrome: is the pathogenesis mediated by
helper T cell type 1 cytokines. J Am Acad Dermatol. 39:940–943.
1998.
|
|
25.
|
Tuerlinckx D, Bodart E, Despontin K, et
al: Sweet’s syndrome with arthritis in a 8-month-old boy. J
Rheumatol. 26:440–442. 1999.
|
|
26.
|
Kawakami T, Ohashi S, Kawa Y, et al:
Elevated serum granulocyte colony-stimulating factor levels in
patients with active phase of Sweet syndrome and patients with
active Behcet disease: implication in neutrophil apoptosis
dysfunction. Arch Dermatol. 140:570–574. 2004. View Article : Google Scholar
|
|
27.
|
Oiso N, Watanabe K and Kawada A:
Granulocyte colony-stimulating factor-induced Sweet syndrome in a
healthy donor. Br J Haematol. 135:1482006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Shinojima Y, Toma Y and Terui T: Sweet
syndrome associated with intrahepatic cholangiocarcinoma producing
granulocyte colony-stimulating factor. Br J Haematol.
154:1103–1104. 2006.
|
|
29.
|
Requena L, Kutzner H, Plamedo G, et al:
Histiocytoid Sweet syndrome: a dermal infiltration of immature
neutrophilic granulocytes. Arch Dermatol. 141:834–842. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Walker DC and Cohen PR:
Trimethoprim-sulfamethoxazole associated acute febrile neutrophilic
dermatosis: case report and review of drug-induced Sweet’s
syndrome. J Am Acad Dermatol. 34:918–923. 1996.PubMed/NCBI
|
|
31.
|
Cohen PR and Kurzrock R: Sweet’s syndrome.
A neutrophilic dermatosis classically associated with acute onset
and fever. Clin Dermatol. 18:265–282. 2000.
|
|
32.
|
Bidyasar S, Montoya M, Suleman K, et al:
Sweet syndrome associated with granulocyte colony-stimulating
factor. J Clin Oncol. 26:4355–4356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Llamas-Velasco M, García-Martín P,
Sánchez-Pérez J, et al: Sweet’s syndrome with subcutaneous
involvement associated with pegfilgrastim treatment: first reported
case. J Cutan Pathol. 40:46–49. 2013.
|
|
34.
|
Van Regenmortel N, Van de Voorde K, De
Raeve H, et al: Bortezomib-induced Sweet’s syndrome. Haematologica.
90:ECR432005.
|
|
35.
|
Tanguy-Schmidt A, Avenel-Audran M, Croué
A, et al: Bortezomib-induced acute neutrophilic dermatosis. Ann
Dermatol Venereol. 136:443–446. 2009. View Article : Google Scholar
|
|
36.
|
Alencar C, Abramowitz M, Parekh S, et al:
Atypical presentations of Sweet’s syndrome in patients with MDS/AML
receiving combinations of hypomethylating agents with histone
deacetylase inhibitors. Am J Hematol. 84:688–689. 2009.
|
|
37.
|
Trickett HB, Cumpston A and Craig M:
Azacitidine-associated Sweet’s syndrome. Am J Health Syst Pharm.
69:869–871. 2012.PubMed/NCBI
|
|
38.
|
Deininger MW, O’Brien SG, Ford JM, et al:
Practical management of patients with chronic myeloid leukemia
receiving imatinib. J Clin Oncol. 21:1637–1647. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Liu D, Seiter K, Mathews T, et al: Sweet’s
syndrome with CML cell infiltration of the skin in a patient with
chronic-phase CML while taking Imatinib Mesylate. Leuk Res.
28(Suppl 1): S61–S63. 2004.
|
|
40.
|
Ayirookuzhi SJ, Ma L, Ramshesh P, et al:
Imatinib-induced Sweet syndrome in a patient with chronic myeloid
leukemia. Arch Dermatol. 141:368–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Hoverson AR, Davis MD, Weenig RH, et al:
Neutrophilic dermatosis (Sweet syndrome) of the hands associated
with lenalidomide. Arch Dermatol. 142:1070–1071. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Thieu KP, Rosenbach M, Xu X, et al:
Neutrophilic dermatosis complicating lenalidomide therapy. J Am
Acad Dermatol. 61:709–710. 2009. View Article : Google Scholar
|
|
43.
|
Tageja N, Giorgadze T and Zonder J:
Dermatological complications following initiation of lenalidomide
in a patient with chronic lymphocytic leukaemia. Intern Med J.
41:286–288. 2011. View Article : Google Scholar
|
|
44.
|
Aue G, Njuguna N, Tian X, et al:
Lenalidomide induced upregulation of CD80 on tumor cells correlates
with T-cell activation, the rapid onset of a cytokine release
syndrome and leukemic cell clearance in chronic lymphocytic
leukemia. Haematologica. 94:1266–1273. 2009. View Article : Google Scholar
|
|
45.
|
Yan ZS, Li DP, Jiang EL, et al:
Development of Sweet syndrome in an acute promyelocyte leukemia
patient during treatment with all-trans retinoic acid - case report
and literature review. Zhonghua Xue Ye Xue Za Zhi. 28:462–465.
2007.PubMed/NCBI
|
|
46.
|
Dubois C, Schlageter MH, de Gentile A, et
al: Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans
retinoic acid in acute promyelocytic leukemia. Leukemia.
8:1750–1757. 1994.PubMed/NCBI
|
|
47.
|
Bielsa S, Baradad M, Marti RM, et al:
Sweet’s syndrome with bullous lesions. Actas Dermosifiliogr.
96:315–316. 2005.
|
|
48.
|
Shugarman IL, Schmit JM, Sbicca JA, et al:
Easily missed extracutaenous manifestation of malignancy associated
Sweet’s syndrome: systemic inflammatory response syndrome. J Clin
Oncol. 29:e702–705. 2011.PubMed/NCBI
|
|
49.
|
Cohen PR: Neutrophilic dermatoses: a
review of current treatment options. Am J Clin Dermatol.
10:301–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Cohen PR and Kurzrock R: Sweet’s syndrome:
a review of current treatment options. Am J Clin Dermatol.
3:117–131. 2002.
|
|
51.
|
Spillman DH, Carabajal MG, Errecaborde MS,
et al: Acute febrile neutrophilic dermatosis (Sweet’s syndrome).
In: Book of Abstracts. 18th World Congress of Dermatology.
Dermatology Progress and Perspectives; June 12–18; New York City.
abs. 147. 1992
|
|
52.
|
Cohen PR, Holder WR, Tucker SB, Kono S and
Kurzrock R: Sweet syndrome in patients with solid tumors. Cancer.
72:2723–2731. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Horio T, Imamura S, Danno K, et al:
Treatment of acute neutrophilic dermatosis (Sweet’s syndrome) with
potassium iodide. Dermatologica. 160:341–347. 1980.
|
|
54.
|
Burrall B: Sweet’s syndrome (acute febrile
neutrophilic dermatosis). Dermatol Online J. 5:81999.
|
|
55.
|
Bourke JF, Keohane S, Long CC, et al:
Sweet’s syndrome and malignancy in the U.K. Br J Dermatol.
137:609–613. 1997.
|
|
56.
|
Maillard H, Leclech C, Peria P, et al:
Colchicine for Sweet’s syndrome. A study of 20 cases. Br J
Dermatol. 140:565–566. 1999.
|
|
57.
|
von den Driesch P, Steffan C, Zobe A, et
al: Sweet’s syndrome-therapy with cyclosporin. Clin Exp Dermatol.
19:274–277. 1994.
|
|
58.
|
Jeanfils S, Joly P, Young P, et al:
Indomethacin treatment of eighteen patients with Sweet’s syndrome.
J Am Acad Dermatol. 36:436–439. 1997.PubMed/NCBI
|
